Koers Fuse Medical, Inc.
Aandelen
FZMD
US36113U1016
Medische apparatuur, benodigdheden & distributie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,05 USD | -32,52% |
|
-32,52% | -56,52% |
Omzet 2021 | 20,41 mln. 19,06 mln. | Omzet 2022 | 18,64 mln. 17,41 mln. | Marktkapitalisatie | 10,55 mln. 9,85 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -1 mln. -934K | Nettowinst (verlies) 2022 | 3 mln. 2,8 mln. | EV/omzet 2021 | 1,59 x |
Nettoschuld 2021 | 2,23 mln. 2,08 mln. | Nettoschuld 2022 | 2,2 mln. 2,05 mln. | EV/omzet 2022 | 0,68 x |
K/w-verhouding 2021 |
-19
x | K/w-verhouding 2022 |
3,75
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 13,11% |
1 dag | -32,52% | ||
1 week | -32,52% | ||
Lopende maand | -39,10% | ||
1 maand | -39,10% | ||
3 maanden | -58,33% | ||
6 maanden | -56,52% | ||
Lopend jaar | -56,52% |
![Extreem 0.05](/images/extremecours_fleche.png)
![Extreem 0.05](/images/extremecours_fleche.png)
![Extreem 0.05](/images/extremecours_fleche.png)
![Extreem 0.0302](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Christopher Reeg
CEO | Chief Executive Officer | 60 | 19-12-16 |
Mark Brooks
CHM | Chairman | 58 | 19-12-16 |
Lawrence Yellin
DFI | Director of Finance/CFO | 66 | 04-04-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lawrence Yellin
DFI | Director of Finance/CFO | 66 | 04-04-22 |
Christopher Reeg
CEO | Chief Executive Officer | 60 | 19-12-16 |
Mark Brooks
CHM | Chairman | 58 | 19-12-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-56,52% | 3,52 mln. | |
-4,92% | 182 mld. | |
-3,70% | 103 mld. | |
-5,29% | 66,94 mld. | |
+10,99% | 46,73 mld. | |
-7,70% | 45,14 mld. | |
+6,33% | 41,57 mld. | |
+15,96% | 30,48 mld. | |
+12,87% | 24,26 mld. | |
-6,63% | 23,58 mld. |